References
- Aoyagi, T., M. Yagisawa, M. Kumagai, M. Hamada, Y. Okami, T. Takeuchi, and H. Umezawa. 1971. An enzyme inhibitor, panosialin, produced by Streptomyces. I. Biological activity, isolation and characterization of panosialin. J. Antibiot. 24: 860-869. https://doi.org/10.7164/antibiotics.24.860
- Campbell, J. W. and J. E. Cronan. 2001. Bacterial fatty acid biosynthesis: Targets for antibacterial drug discovery. Annu. Rev. Microbiol. 55: 305-332. https://doi.org/10.1146/annurev.micro.55.1.305
- Collins, L. A., M. N. Torrero, and S. G. Franzblau. 1998. Green fluorescent protein reporter microplate assay for highthroughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 42: 344-347.
- Heath, R. J. and C. O. Rock. 2004. Fatty acid biosynthesis as a target for novel antibacterials. Curr. Opin. Investig. Drugs 5: 146-153
- Kumagai, M., Y. Suhara, T. Aoyagi, and H. Umezawa. 1971. An enzyme inhibitor, panosialin, produced by Streptomyces. II. Chemistry of panosialin, 5-alkylbenzene-1,3-disulfates. J. Antibiot. 24: 870-875. https://doi.org/10.7164/antibiotics.24.870
- Kwon, Y. J., Y. Fang, G. H. Xu, and W. G. Kim. 2009. Aquastatin A, a new inhibitor of enoyl-acyl carrier protein reductase from Sporothrix sp. FN611. Biol. Pharm. Bull. 32: 2061-2064. https://doi.org/10.1248/bpb.32.2061
- McMurry, L. M., M. Oethinger, and S. B. Levy. 1998. Triclosan targets lipid synthesis. Nature 394: 531-532. https://doi.org/10.1038/28970
- Moir, D. T. 2005. Identification of inhibitors of bacterial enoylacyl carrier protein reductase. Curr. Drug Targets Infect. Disord. 5: 297-305. https://doi.org/10.2174/1568005054880154
- Rozwarski, D. A., G. A. Grant, D. H. R. Barton, W. R. Jacobs Jr., and J. C. Sacchettini. 1998. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science 279: 98-102. https://doi.org/10.1126/science.279.5347.98
- Yamada, H., K. Shiomi, Q. Xu, T. Nagai, M. Shibata, I. Oya, et al. 1995. New glycosidases inhibitors, panosialins D and wD produced by Streptomyces sp. OH-5186. J. Antibiot. 48: 205-210 https://doi.org/10.7164/antibiotics.48.205
- Zhang, Y. M., S. W. White, and C. O. Rock. 2006. Inhibiting bacterial fatty acid synthesis. J. Biol. Chem. 281: 17541-17544. https://doi.org/10.1074/jbc.R600004200
- Zheng, C. J., M. J. Sohn, S.-W. Chi, and W. G. Kim. 2010. Methyl-branched fatty acids, inhibitors of enoyl-ACP reductase with antibacterial activity from Streptomyces sp. A251. J. Microbiol. Biotechnol. 20: 875-880. https://doi.org/10.4014/jmb.1001.01004
- Zheng, C. J., M. J. Sohn, and W. G. Kim. 2009. Vinaxanthone, a new FabI inhibitor from Penicillium sp. J. Antimicrob. Chemother. 63: 949-953. https://doi.org/10.1093/jac/dkp058
Cited by
- Recent advances in inhibitors of bacterial fatty acid synthesis type???II (FASII) system enzymes as potential antibacterial agents. vol.8, pp.10, 2013, https://doi.org/10.1002/cmdc.201300209